论文部分内容阅读
目的:探讨联合用药在治疗多囊卵巢综合征不孕的临床疗效。方法:将70例多囊卵巢综合征不孕症患者随机分为观察组和对照组,每组35例,两组均给予口服达英-35,1片/d,连服21d,观察组在此基础上联合使用来曲唑以及肌注绒毛膜促性腺激素促排卵,观察两组患者治疗后内分泌激素的变化以及治疗效果。结果:观察组患者用药后促黄体生成素、睾酮、促黄体生成素/促卵泡素比值等指标均有明显改善,妊娠率60.0%,较对照组的45.7%有显著提高,差异有统计学意义,P<0.05。结论:达英-35联合来曲唑治疗多囊卵巢综合征可以调整患者机体内激素环境,改善高雄激素状态,有效提高妊娠率。
Objective: To explore the clinical efficacy of combination therapy in the treatment of infertility with polycystic ovary syndrome. Methods: Seventy patients with polycystic ovary syndrome infertility were randomly divided into observation group and control group, 35 cases in each group. Both groups were given oral Ying -35, 1 tablet / d, Based on the combination of letrozole and intramuscular injection of human chorionic gonadotropin to promote ovulation, the changes of the two groups of patients after treatment of endocrine hormones and therapeutic effect was observed. Results: The indexes of luteinizing hormone, testosterone, luteinizing hormone / follicle stimulating hormone in observation group were significantly improved after treatment, the pregnancy rate was 60.0%, which was significantly higher than 45.7% in control group, the difference was statistically significant, P <0.05. CONCLUSION: Da-Ying-35 combined with letrozole in the treatment of polycystic ovary syndrome can adjust the hormone environment, improve the state of hyperandrogenism and increase the pregnancy rate effectively.